<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02845765</url>
  </required_header>
  <id_info>
    <org_study_id>N.2015 FundusOculi_DE</org_study_id>
    <nct_id>NCT02845765</nct_id>
  </id_info>
  <brief_title>Fundus Oculi and Erectile Dysfunction</brief_title>
  <official_title>Evaluation of Vascularization of the Fundus Oculi in Patients With Erectile Dysfunction as Barometer of Patient's Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale San Raffaele</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the correlation between fundus oculi's
      vascularization in patients with erectile dysfunction and not, and, in the same patients,
      before and after using drugs for ED.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the correlation between fundus oculi's
      vascularization in patients with erectile dysfunction and not, and, in the same patients,
      before and after using drugs for ED.

      In this monocentric, prospective, observational case-control study 40 eyes of 40 patients
      affected by erectile dysfunction and 20 healthy age-matched controls will be enrolled.

      Patients will undergo DVA examination at baseline and 6 months after PDE5I therapy. Healthy
      subjects will be examined with DVA at baseline only.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Static and dynamic retinal vessels diameter</measure>
    <time_frame>Baseline and after 6 month of therapy</time_frame>
    <description>Analysis of the presence and prevalence of retinal vascularization alterations using Dynamic Vessel Analyzer (DVA) in patients with Erectile Dysfunction and in subject healthy volunteers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>International Index of Erectile Function (IIEF) Questionnaire</measure>
    <time_frame>After 6 month of therapy</time_frame>
    <description>Revaluation of the correlation between Erectile Dysfunction and Fundus Oculi vascularization after 6 month of therapy for ED.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Patients with erectile dysfunction</arm_group_label>
    <description>Patients with erectile dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Patients will be examined with Dynamic Vessel Analyzer (DVA) at baseline and 6 months after therapy with Phosphodiesterase type 5 Inhibitor (PDE5I).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subject healthy volunteers</arm_group_label>
    <description>Patients without erectile dysfunction or ocular disease. Patients will be examined with Dynamic Vessel Analyzer (DVA) at baseline</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dynamic Vessel Analyzer (DVA)</intervention_name>
    <arm_group_label>Patients with erectile dysfunction</arm_group_label>
    <arm_group_label>Subject healthy volunteers</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phosphodiesterase type 5 Inhibitor (PDE5I)</intervention_name>
    <arm_group_label>Patients with erectile dysfunction</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  n. 40 patients with erectile dysfunction haracterized by the inability to develop or
             maintain an erection of the penis during sexual activity

          -  n. 20 subject healthy volunteers without erectile dysfunction or ocular desease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with erectile dysfunction diagnosis (organic and psychogenic);

          -  Subjects with Erectile Dysfunction diagnosis defined by IIEF score â‰¤ 25

          -  Subjects with stable partner for at least 6 months and sexually active.

          -  Subjects aged between 40 - 60 years;

          -  Signature of informed consent for patients

        Exclusion Criteria:

          -  Subjects with ED secondary diagnosis to hormonal alterations (i.e. hypogonadism, hypo
             / hyperthyroidism, hyperprolactinemia);

          -  Subjects with a diagnosis of ED post-traumatic and iatrogenic, since after pelvic
             surgery;

          -  Subjects suffering from any ocular pathology that involves use of contact lenses and /
             or glasses;

          -  Subjects smoking;

          -  Individuals with uncontrolled systemic diseases;

          -  All persons who do not confirm at least one criterion for inclusion.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Salonia, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Vita-Salute, San Raffaele Hospital - Milan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Giuseppe Querques, MD, PhD</last_name>
    <phone>+39 0226434004</phone>
    <email>giuseppe.querques@hotmail.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roberta Scano</last_name>
    <phone>+39 0226435506</phone>
    <email>scano.roberta@hsr.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milan</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Querques, MD, PhD</last_name>
      <phone>+39 0226434004</phone>
      <email>giuseppe.querques@hotmail.it</email>
    </contact>
    <contact_backup>
      <last_name>Costantino Abbate</last_name>
      <phone>+39 0226435628</phone>
      <email>abbate.costantino@hsr.it</email>
    </contact_backup>
    <investigator>
      <last_name>Andrea Salonia, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2016</study_first_submitted>
  <study_first_submitted_qc>July 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>October 7, 2017</last_update_submitted>
  <last_update_submitted_qc>October 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale San Raffaele</investigator_affiliation>
    <investigator_full_name>Querques Giuseppe</investigator_full_name>
    <investigator_title>Head-Medical retina &amp; Imaging unit</investigator_title>
  </responsible_party>
  <keyword>Erectile Dysfunction</keyword>
  <keyword>ED</keyword>
  <keyword>Fundus Oculi</keyword>
  <keyword>Retinal Vascularization</keyword>
  <keyword>International Index of Erectile Function Questionnaire</keyword>
  <keyword>IIEF</keyword>
  <keyword>Dynamic Vessel Analyzer</keyword>
  <keyword>DVA</keyword>
  <keyword>Phosphodiesterase type 5 Inhibitor</keyword>
  <keyword>PDE5Is</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
    <mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

